Akebia Therapeutics Newsroom

Akebia Therapeutics to Present at the Jefferies Global Healthcare Conference

PRNewswireMay 23 08:00 ET

Breakeven On The Horizon For Akebia Therapeutics, Inc. (NASDAQ:AKBA)

With the business potentially at an important milestone, we thought we'd take a closer look at Akebia Therapeutics, Inc.'s (NASDAQ:AKBA) future prospects. Akebia Therapeutics, Inc., a biopharmaceutic

Simply Wall StMay 13 06:29 ET

Revenue Downgrade: Here's What Analysts Forecast For Akebia Therapeutics, Inc. (NASDAQ:AKBA)

Yahoo FinanceMay 11 09:21 ET

Akebia Therapeutics Reports Q1 2024 Financial Results: A Detailed Overview

Yahoo FinanceMay 10 15:27 ET

Akebia Therapeutics, Inc. (NASDAQ:AKBA) Q1 2024 Earnings Call Transcript

Yahoo FinanceMay 10 15:06 ET

Akebia Therapeutics First Quarter 2024 Earnings: Misses Expectations

Yahoo FinanceMay 10 09:19 ET

Akebia Therapeutics(AKBA.US) Officer Sells US$31,050 in Common Stock

$Akebia Therapeutics(AKBA.US)$ Officer Burke Steven Keith sold 27,000 shares of common stock on Aug 25, 2023 at an average price of $1.15 for a total value of $31,050.Source: Announcement What is stat

moomoo NewsMay 9 18:07 ET

Tivic Health, RAPT Therapeutics, Notable Labs Among Healthcare Movers

Seeking AlphaMay 9 10:00 ET

Express News | Akebia Therapeutics Shares Are Trading Lower After the Company Reported Worse-than-expected Q1 Financial Results

BenzingaMay 9 08:24 ET

Earnings Flash (AKBA) AKEBIA THERAPEUTICS Reports Q1 Revenue $32.6M

07:14 AM EDT, 05/09/2024 (MT Newswires) -- Earnings Flash (AKBA) AKEBIA THERAPEUTICS Reports Q1 Revenue $32.6M

MT NewswiresMay 9 07:14 ET

Akebia Therapeutics | 10-Q: Quarterly report

Futu NewsMay 9 07:07 ET · Announcements

Express News | Akebia Therapeutics: Existing Cash Resources Sufficient to Fund Current Operating Plan, Including U.S. Vafseo Launch, for at Least Next 2 Years

ReutersMay 9 07:05 ET

Express News | Akebia Therapeutics Q1 Operating Income USD -14.936 Million

ReutersMay 9 07:00 ET

Express News | Akebia Therapeutics Q1 Basic EPS USD -0.09

ReutersMay 9 07:00 ET

Express News | Akebia Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights

ReutersMay 9 07:00 ET

Express News | Akebia Therapeutics Q1 Net Income USD -17.985 Million

ReutersMay 9 07:00 ET

Express News | Akebia Therapeutics Q1 Operating Expenses USD 35.938 Million

ReutersMay 9 07:00 ET

Akebia Therapeutics 1Q Loss/Shr 9c >AKBA

Akebia Therapeutics 1Q Loss/Shr 9c >AKBA

Dow JonesMay 9 07:00 ET

Akebia Therapeutics to Report First Quarter 2024 Financial Results and Discuss Recent Business Highlights

Akebia Therapeutics, Inc. (Nasdaq: AKBA) today announced plans to release its financial results for the first quarter ended March 31, 2024, on...

PR NewswireMay 2 08:30 ET

When Can We Expect A Profit From Akebia Therapeutics, Inc. (NASDAQ:AKBA)?

Yahoo FinanceApr 28 10:23 ET